The global precision medicine software market size has the potential to grow by USD 882.65 million during 2020-2024. The market’s growth momentum will accelerate throughout the forecast period because of the steady increase in year-over-year growth.

This report provides a detailed analysis of the market by delivery mode (on-premise and cloud-based) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including F. Hoffmann-La Roche Ltd., Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., International Business Machines Corp., Koninklijke Philips NV, NantHealth Inc., Roper Technologies Inc., SOPHiA GENETICS SA, and Syapse Inc. View Free Sample Report

Precision Medicine Software Market: Key Trends to impact market growth

The digitization of healthcare is one of the key precision medicine software market market trends. This research report provides a detailed impact analysis of all the trends that are likely to influence the growth of the market in focus.

Precision Medicine Software Market: Top Drivers to Boost Demand

The benefits of precision medicine is one of the primary factors driving the growth of the precision medicine software market. The report provides a detailed study of all the factors that are likely to boost the market. This analysis will enable clients to leverage growth opportunities to their advantage and set their business

Vendor Analysis: F. Hoffmann-La Roche Ltd., Fabric Genomics Inc. and Gene42 Inc. are key growth contributors

The market is fragmented. The research report provides insights into the top market player and their product portfolio along with a pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. F. Hoffmann-La Roche Ltd., Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., International Business Machines Corp., Koninklijke Philips NV, NantHealth Inc., Roper Technologies Inc., SOPHiA GENETICS SA, and Syapse Inc. are some of the major market participants.

For more insights on this market: Download a Free Sample Report

Precision Medicine Software Market: Key Highlights of the Report for 2020-2024

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will drive precision medicine software market growth during the next five years
• Precise estimation of the precision medicine software market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the precision medicine software market industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of precision medicine software market vendors

Precision Medicine Software Market to Grow by USD 882.65 mn through 2020-2024

The Global Precision Medicine Software Market is expected to grow by USD 882.65 million accelerating at a CAGR of over 6% during the forecast period. The healthcare industry is expected to witness positive growth as a result of COVID-19, and the impact of the pandemic on the market in focus is also expected to remain neutral. Technavio evaluates the market with a detailed investigation into the market forces, emerging trends, and growth drivers. It also provides competitive benchmarking to equip clients with actionable insights that will help them navigate through the current market scenario. Preview our latest report with COVID-19 Impact Analysis

"The growing demand for precision medicine will drive the growth of the Global Precision Medicine Software Market in the forthcoming years. 34% of the market’s growth will originate from North America during the forecast period."

Precision Medicine Software Market: Market LandscapeSegment Highlights

• Market Landscape Segmentation: On-Premise, Cloud-Based
• On-premise software systems can be operated even without access to the Internet, which is particularly useful in places where Internet connectivity is weak or unreliable. These factors are driving the precision medicine software market growth by the on-premise segment.

Precision Medicine Software Market: Competitive Analysis

• The Precision Medicine Software Market is fragmented due to the presence of several vendors.
• Market vendors focused on developing advanced interventional cardiology products, market expansion, innovations, and expansion of distribution networks.
• F. Hoffmann-La Roche Ltd., Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., International Business Machines Corp., Koninklijke Philips NV, NantHealth Inc., Roper Technologies Inc., SOPHiA GENETICS SA, and Syapse Inc. are some of the major market participants. Although the growing demand for MI procedures will offer immense growth opportunities, the high cost of precision medicine software procedures will challenge the growth of the market participants. 

Technavio provides custom research reports with detailed insights on the impact of COVID-19 with respect to the industry, region, and supply chain operations. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations. Download a Free Sample Report